Generic Name: Ranibizumab
Brand Name: Lucentis
Manufacturer: Novartis Pharmaceuticals Inc.
Therapeutic Area: Macular degeneration, age-related
Indications: Macular degeneration, age-related
Submission Type: Initial
Project Status: Complete
Date Recommendation Issued: March 27, 2008
Recommendation Type: List with clinical criteria and/or conditions